Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1736 of 6351
-
Could a common antibiotic boost rectal cancer therapy?
Disease control Recruiting nowTo learn if adding metronidazole to standard therapy can decrease populations of Fusobacterium nucleatum (F. nucleatum) and other anaerobes (small organisms that cause infections) in participants with rectal cancer receiving neoadjuvant therapy, compared to neoadjuvant therapy al…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New antibody takes aim at Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a CLDN6-directed T cell-engaging bispecific antibody , in participants with platinum-refractory/resistant ovarian cancer (PRROC) and other advanced …
Phase 1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Cholesterol drug may shield ears from chemo damage
Symptom relief Recruiting nowBackground: Cisplatin is used to treat head and neck cancer. People who take this drug are at risk for hearing loss. Atorvastatin is a drug used to treat high cholesterol. It might reduce the risk of cisplatin-induced hearing loss. Objective: To find out if atorvastatin reduce…
Phase 2 • Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New telehealth program aims to help autistic teens master daily chores before adulthood
Symptom relief Recruiting nowThe current study seeks to compare outcomes of a telehealth intervention targeting daily living skills (Surviving and Thriving in the Real World - Telehealth, or STRW-T) intervention to a control group telehealth intervention targeting social skills (Program for the Education and…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New drug radiprodil tested for tough seizures in two brain conditions
Disease control OngoingStudy RAD-GRIN-201 is a phase 1B/2A trial to assess safety, tolerability, pharmacokinetics (PK), and potential efficacy of radiprodil in participants with Tuberous Sclerosis Complex (TSC) or Focal Cortical Dysplasia (FCD) type II. The study is open-label, so all participants will…
Phase 1/2 • Sponsor: GRIN Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New study explores best guselkumab dose for psoriasis in chinese patients
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, tolerability and drug survival of guselkumab in high-dose and extended-interval versus standard-dose in Chinese participants with moderate to severe plaque psoriasis.
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can parent training ease autism symptoms in young children?
Disease control By invitation onlyThe aim of this study is to evaluate the effectiveness of a parent training program on the severity of autism-related symptoms in two groups: (1) infants under the age of 2 who show early signs of autism, and (2) children aged 2 to 5 years who have been diagnosed with Autism Spec…
Sponsor: Umraniye Education and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can an Antibiotic-Laced bone graft make dental implants more reliable?
Disease control CompletedAdding local vancomycin to xenografts greatly benefits stability, bone density, and limits marginal bone loss in dental implants in infected socket.
Phase 1 • Sponsor: Al-Azhar University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can body weight predict success of knee realignment surgery?
Disease control CompletedThe knee joint plays a major role in weight transmission of the body in day-to-day activities. The biomechanics of the knee and malalignment in lower limb anatomy are major risk factors for chronic knee pain, leaving Total Knee Arthroplasty (TKA) as the best and most successful o…
Sponsor: Egymedicalpedia • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New blood marker could help doctors catch sepsis days sooner
Diagnosis CompletedIn this study, 250 patients with high-risk of sepsis will be enrolled, including ≥ 50 subjects with confirmed sepsis. Diagnostic criteria for sepsis should meet the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), i.e., simultaneously meet the fol…
Sponsor: Fapon Biotech Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
New drug 611 shows promise for kids with severe eczema
Disease control CompletedThe primary objective of the study was to evaluate the safety and pharmacokinetic of 611 in Chinese children and adolescents with moderate to severe atopic dermatitis.
Phase 1/2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New balloon zaps away AFib without heat
Disease control OngoingThe goal of this clinical trial is to assess the safety and effectiveness of a conformal pulsed field ablation (PFA) balloon catheter for pulmonary vein isolation (PVI) in patients with paroxysmal atrial fibrillation (AF). It will also explore the durable effectiveness of this no…
Sponsor: The Third People's Hospital of Chengdu • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blood-based injections offer new hope for women with bladder leaks
Disease control Completedcompare the therapeutic effect of periurethral injection of autologous platelet-rich plasma (PRP) and injectable platelet rich fibrin (i-PRF) in treatment of female stress urinary incontinence and comparing the need for re-injection in the two groups.
Phase 3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New antibiotic pill could heal Flesh-Eating ulcers in weeks
Disease control Recruiting nowThe goal of this interventional clinical trial is to demonstrate the complete BU lesion healing rate by 52 weeks after treatment initiation, without relapse and/or curative intent excision surgery, after 10-28 days of telacebec (T) treatment. Males and females age 18 and older wi…
Phase 2 • Sponsor: Barwon Health • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New trial aims to stop deadly bleeding after birth
Disease control Recruiting nowThe goal of this trial is to determine if postpartum blood loss can be reduced by replenishing coagulation factor XIII (FXIII) at an early stage of postpartum hemorrhage (PPH). Summary of current body of evidence: * Morbidity and mortality due to PPH is rising. * Current guidel…
Phase 4 • Sponsor: Christian Haslinger • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Eye injection could spot hidden brain bleeding risk
Diagnosis Recruiting nowThe purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with cerebral amyloid angiopathy (CAA).
Phase 2 • Sponsor: Amydis Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Vitamin e derivative tested to halt pancreatic cyst growth
Prevention OngoingThis is a randomized, double-blind, placebo-controlled trial, investigating whether treatment with δ-tocotrienol (a.k.a. Delta-tocotrienol, abbreviated as DT3) will prevent the progression of Intraductal Papillary Mucinous Neoplasm (IPMN) of the pancreas.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Could an Anti-Inflammatory pill help control diabetes?
Disease control Recruiting nowThe aim of the study is to determine whether NLRP3 inhibition with dapansutrile represents a new pharmacological option for diabetes management with potential as an anti-inflammatory agent to also address micro- and macro-vascular risk and complications from diabetes.
Phase 2 • Sponsor: Marc Donath • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can tailored brain training tame ADHD symptoms?
Symptom relief Recruiting nowThe first aim of this clinical trial is to test the feasibility and signal validity of a new approach to neurofeedback training (NF) using intensive EEG-based theta-beta NF for children with ADHD in the context of NF camps during school holidays. The second aim is to compare the …
Sponsor: Bielefeld University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can a classroom curriculum stop child sex trafficking? large trial launches
Prevention Recruiting nowThe overall goal of the five-year project is to conduct both a process and rigorous outcome evaluation of The Set Me Free Project (SMFP)'s READY to Stand (RTS)© curriculum with an eye toward widespread dissemination to other U.S. communities, if deemed effective. Broadly, the inv…
Sponsor: University of Michigan • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC